# US 2019/0167999 A1 · Implantable neurostimulator-implemented method for managing tachyarrhythmia through vagus nerve stimulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167999 A1
- Document ID: US20190167999A1
- Status: Published application
- Kind: A1
- Application number: 16/265,770
- Filed: 2019-02-01
- Published: 2019-06-06
- Earliest claimed: 2012-11-09
- Assignees: LivaNova USA, Inc.
- Applicants: LivaNova USA, Inc.
- Inventors: Imad Libbus; Badri Amurthur; Bruce H. KenKnight
- Web page: https://patentgrep.com/patent/US20190167999A1

## CPC

- A61N 1/36114: {Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362)}
- A61B 5/0245: by using sensing means generating electric signals, {i.e. ECG signals}
- A61B 5/352: Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
- A61B 5/363: Detecting tachycardia or bradycardia
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/686: {Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence)}
- A61N 1/36053: {adapted for vagal stimulation (A61N1/36114 takes precedence)}
- A61N 1/36139: {with automatic adjustment}
- A61N 1/3621: {for treating or preventing abnormally high heart rate}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

An implantable neurostimulator-implemented method for managing tachyarrhythmias through vagus nerve stimulation is provided. An implantable neurostimulator, including a pulse generator, is configured to deliver electrical therapeutic stimulation in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers of a patient's cervical vagus nerve. Operating modes of the pulse generator are stored. A maintenance dose of the electrical therapeutic stimulation is delivered to the vagus nerve via the pulse generator to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. A restorative dose of the electrical therapeutic stimulation is delivered to prevent initiation of or disrupt tachyarrhythmia through periodic electrical pulses delivered at higher intensity than the maintenance dose. The patient's normative physiology is monitored via a physiological sensor, and upon sensing a condition indicative of tachyarrhythmia, is switched to delivering the restorative dose to the vagus nerve.

## Claims

### Claim 1

An implantable neurostimulator for managing tachyarrhythmias through vagus nerve stimulation, comprising:
a pulse generator configured to generate electrical stimulation;
a processor; and
a memory having instructions stored thereon that, when executed by the processor, cause the processor to:
define a maintenance dose of the electrical stimulation;
define a restorative dose of the electrical stimulation comprising electrical pulses delivered at a higher intensity than the maintenance dose;
deliver the maintenance dose to an electrode assembly, via the pulse generator, prior to delivering the restorative dose, prior to sensing a condition of tachyarrhythmia, and independent of cardiac cycle;
monitor a patient's normative physiology to sense the condition of tachyarrhythmia via a physiological sensor;
upon sensing the condition of tachyarrhythmia, switch from delivering the maintenance dose to delivering the restorative dose; and
upon sensing a condition indicative of a recurrence of the tachyarrythmia, continue delivery of the restorative dose.

### Claim 2 (depends on 1)

The implantable neurostimulator of claim 1, wherein the higher intensity of the restorative dose comprises at least one of a higher output current, higher duty cycle, higher frequency, or longer pulse width than the maintenance dose.

### Claim 3 (depends on 1)

The implantable neurostimulator of claim 1, wherein the instructions further cause the processor to sense the condition indicative of tachyarrhythmia based on at least one of an abnormal sinus rhythm of the patient or a heart rate of the patient rising above a maximum threshold.

### Claim 4 (depends on 1)

The implantable neurostimulator of claim 1, wherein the instructions further cause the processor to, upon sensing a condition indicative of a recurrence of the tachyarrhythmia, continue delivery of the restorative dose at an increased intensity.

### Claim 5 (depends on 4)

The implantable neurostimulator of claim 4, wherein the instructions further cause the processor to, upon sensing the condition indicative of a recurrence of the tachyarrhythmia, continue delivery of the restorative dose at the increased intensity by:
determining whether the condition of tachyarrhythmia is at least one of a life-threatening or paroxysmal arrhythmia, wherein the at least one of a life-threatening or paroxysmal arrhythmia is associated with a first increased intensity; and
upon determining that the condition of tachyarrhythmia is at least one of a life-threatening or paroxysmal arrhythmia, increase the intensity of the restorative dose to the first increased intensity.

### Claim 6 (depends on 4)

The implantable neurostimulator of claim 4, wherein the instructions further cause the processor to, upon sensing the condition indicative of a recurrence of the tachyarrhythmia, continue delivery of the restorative dose at the increased intensity by:
determining whether the condition of tachyarrhythmia is at least one of a life-threatening or paroxysmal arrhythmia, wherein the at one of a life-threatening or paroxysmal arrhythmia is associated with a first increased intensity; and
upon determining that the condition of tachyarrhythmia is not at least one of a life-threatening or paroxysmal arrhythmia, increase the intensity of the restorative dose to a second increased intensity less than the first increased intensity.

### Claim 7 (depends on 1)

The implantable neurostimulator of claim 1, wherein the instructions further cause the processor to, after continuing delivery of the restorative dose and upon sensing another condition indicative of a recurrence of the tachyarrhythmia, terminate delivery of the restorative dose.

### Claim 8

A method for managing tachyarrhythmia through vagus nerve stimulation, comprising:
defining a maintenance dose of electrical stimulation;
defining a restorative dose of the electrical stimulation comprising electrical pulses delivered at a higher intensity than the maintenance dose;
delivering, using a pulse generator of an implantable medical device, the maintenance dose, prior to delivering the restorative dose, prior to sensing a condition of tachyarrhythmia, and independent of cardiac cycle;
monitoring, using a sensor of the implantable medical device, a patient's normative physiology to sense the condition of tachyarrhythmia;
upon sensing the condition of tachyarrhythmia, switching from delivering the maintenance dose to delivering the restorative dose; and
upon sensing a condition indicative of a recurrence of the tachyarrhythmia, continuing delivery of the restorative dose.

### Claim 9 (depends on 8)

The method of claim 8, wherein the higher intensity of the restorative dose comprises at least one of a higher output current, higher duty cycle, higher frequency, or longer pulse width than the maintenance dose.

### Claim 10 (depends on 8)

The method of claim 8, wherein monitoring, using the sensor, the patient's normative physiology to sense the condition of tachyarrhythmia comprises monitoring, using the sensor, the patient's normative physiology to sense the condition of tachyarrhythmia based on at least one or an abnormal sinus rhythm of the patient or a heart rate of the patient rising above a maximum threshold.

### Claim 11 (depends on 8)

The method of claim 8, wherein, upon sensing the condition indicative of a recurrence of the tachyarrhythmia, continuing the delivery of the restorative dose comprises continuing the delivery of the restorative dose at an increased intensity.

### Claim 12 (depends on 11)

The method of claim 11, wherein, upon sensing the condition indicative of a recurrence of the tachyarrhythmia, continuing the delivery of the restorative dose at the increased intensity comprises:
determining whether the condition of tachyarrhythmia is at least one of a life-threatening or paroxysmal arrhythmia, wherein the at least one of the life-threatening or paroxysmal arrhythmia is associated with a first increased intensity; and
upon determining that the condition of tachyarrhythmia is at least one of a life-threatening or paroxysmal arrhythmia, increasing the intensity of the restorative dose to the first increased intensity.

### Claim 13 (depends on 11)

The method of claim 11, wherein, upon sensing the condition indicative of a recurrence of the tachyarrhythmia, continuing the delivery of the restorative dose at the increased intensity comprises:
determining whether the condition of tachyarrhythmia is at least one of a life-threatening or paroxysmal arrhythmia, wherein the at least one of the life-threatening or paroxysmal arrhythmia is associated with a first increased intensity; and
upon determining that the condition of tachyarrhythmia is not at least one of a life-threatening or paroxysmal arrhythmia, increasing the intensity of the restorative dose to a second increased intensity less than the first increased intensity.

### Claim 14 (depends on 8)

The method of claim 8, further comprising, after continuing delivery of the restorative dose and upon sensing another condition indicative of a recurrence of the tachyarrhythmia, terminating delivery of the restorative dose.

### Claim 15

A non-transitory computer-readable medium comprising instructions executable by a processor of an implantable medical device to perform operations comprising:
defining a maintenance dose of electrical stimulation;
defining a restorative dose of the electrical stimulation comprising electrical pulses delivered at a higher intensity than the maintenance dose;
delivering, using a pulse generator of the implantable medical device, the maintenance dose, prior to delivering the restorative dose, prior to sensing a condition of tachyarrhythmia, and independent of cardiac cycle;
monitoring, using a sensor of the implantable medical device, a patient's normative physiology to sense the condition of tachyarrhythmia;
upon sensing the condition of tachyarrhythmia, switching from delivering the maintenance dose to delivering the restorative dose; and
upon sensing a condition indicative of a recurrence of the tachyarrhythmia, continuing delivery of the restorative dose.

### Claim 16 (depends on 15)

The non-transitory computer-readable medium of claim 15, the higher intensity of the restorative dose comprises at least one of a higher output current, a higher duty cycle, higher frequency, or longer pulse width than the maintenance dose.

### Claim 17 (depends on 15)

The non-transitory computer-readable medium of claim 15, wherein monitoring, using the sensor, the patient' normative physiology to sense the condition of tachyarrhythmia comprises monitoring, using the sensor, the patient's normative physiology to sense the condition of tachyarrhythmia based on at least one of an abnormal sinus rhythm of the patient or a heart rate of the patient rising above a maximum threshold.

### Claim 18 (depends on 15)

The non-transitory computer-readable medium of claim 15, wherein, upon sensing the condition indicative of a recurrence of the tachyarrhythmia, continuing the delivery of the restorative dose comprises continuing the delivery of the restorative dose at an increased intensity.

### Claim 19 (depends on 18)

The non-transitory computer-readable medium of claim 18, wherein, upon sensing the condition indicative of a recurrence of the tachyarrhythmia, continuing the delivery of the restorative dose at the increased intensity comprises:
determining whether the condition of tachyarrhythmia is at least one of a life-threatening or paroxysmal arrhythmia, wherein the at least one of the life-threatening or paroxysmal arrhythmia is associated with a first increased intensity; and
upon determining that the condition of tachyarrhythmia is not at least one of a life-threatening or paroxysmal arrhythmia, increasing the intensity of the restorative dose to a second increased intensity less than the first increased intensity.

### Claim 20 (depends on 15)

The non-transitory computer-readable medium of claim 15, wherein the operations further comprise, after continuing delivery of the restorative dose and upon sensing another condition indicative of a recurrence of the tachyarrhythmia, terminating delivery of the restorative dose.
